Status:
RECRUITING
Covid-19 Long Immunité IMagerie (CLIIM)
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
COVID Long-Haul
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Covid-long pathology affects a large number of patients, and represents a major medical, economic and societal challenge. To date, we have no objective criterion for a definitive diagnosis, nor any pr...
Eligibility Criteria
Inclusion
- FOR CL+ PATIENTS
- Case definition in line with WHO Delphi process
Exclusion
- History of chronic fatigue syndrome diagnosed before or after Covid.
- History of progressive psychiatric pathology.
- History of acute Covid requiring admission to intensive care and mechanical ventilation.
- No social security affiliation.
- FOR CONTROL (CL-)
- Inclusion Criteria:
- History of acute COVID-19, mild, moderate or severe (episode at least 3 months at the time of inclusion).
- Absence of persistent symptoms more than 3 months after first Covid symptoms (or mild not affecting daily activities).
Key Trial Info
Start Date :
December 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06528171
Start Date
December 6 2024
End Date
September 1 2026
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de NICE
Nice, France, 06200